Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT

Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combines the Revised International Staging System (R-ISS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, Yoo Jin Lee, Sang Eun Yoon, Sung-Soo Park, Do Young Kim, Ho-Jin Shin, Yeung-Chul Mun, Jun Ho Yi, Hyo Jung Kim, Da Jung Kim, Ho Sup Lee, Sung Hwa Bae, Chae Moon Hong, Shin Young Jeong, Jung-Joon Min, Sang Kyun Sohn, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Joon Ho Moon, The Korean Multiple Myeloma Working Party
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/0960ae35758a464c82ae284b692a6988
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0960ae35758a464c82ae284b692a6988
record_format dspace
spelling oai:doaj.org-article:0960ae35758a464c82ae284b692a69882021-12-05T12:25:50ZDevelopment of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT10.1038/s41408-021-00577-22044-5385https://doaj.org/article/0960ae35758a464c82ae284b692a69882021-12-01T00:00:00Zhttps://doi.org/10.1038/s41408-021-00577-2https://doaj.org/toc/2044-5385Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combines the Revised International Staging System (R-ISS) with FL, we analyzed the data of 380 patients with newly diagnosed MM (NDMM) who underwent 18F-fluorodeoxyglucose (18F-FDG) PET/CT upon diagnosis. The K-adaptive partitioning algorithm was adopted to define subgroups with homogeneous survival. The combined R-ISS with PET/CT classified NDMM patients into four groups: R-ISS/PET stage I (n = 31; R-ISS I with FL ≤ 3), stage II (n = 156; R-ISS I with FL > 3 and R-ISS II with FL ≤ 3), stage III (n = 162; R-ISS II with FL > 3 and R-ISS III with FL ≤ 3), and stage IV (n = 31; R-ISS III with FL > 3). The 2-year overall survival rates for stages I, II, III, and IV were 96.7%, 89.8%, 74.7%, and 50.3%. The 2-year progression-free survival rates were 84.1%, 64.7%, 40.8%, and 17.1%, respectively. The new R-ISS/PET was successfully validated in an external cohort. This new system had a remarkable prognostic power for estimating the survival outcomes of patients with NDMM. This system helps discriminate patients with a good prognosis from those with a poor prognosis more precisely.Hee Jeong ChoSung-Hoon JungJae-Cheol JoYoo Jin LeeSang Eun YoonSung-Soo ParkDo Young KimHo-Jin ShinYeung-Chul MunJun Ho YiHyo Jung KimDa Jung KimHo Sup LeeSung Hwa BaeChae Moon HongShin Young JeongJung-Joon MinSang Kyun SohnChang-Ki MinKihyun KimJe-Jung LeeJoon Ho MoonThe Korean Multiple Myeloma Working PartyNature Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBlood Cancer Journal, Vol 11, Iss 12, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hee Jeong Cho
Sung-Hoon Jung
Jae-Cheol Jo
Yoo Jin Lee
Sang Eun Yoon
Sung-Soo Park
Do Young Kim
Ho-Jin Shin
Yeung-Chul Mun
Jun Ho Yi
Hyo Jung Kim
Da Jung Kim
Ho Sup Lee
Sung Hwa Bae
Chae Moon Hong
Shin Young Jeong
Jung-Joon Min
Sang Kyun Sohn
Chang-Ki Min
Kihyun Kim
Je-Jung Lee
Joon Ho Moon
The Korean Multiple Myeloma Working Party
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
description Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combines the Revised International Staging System (R-ISS) with FL, we analyzed the data of 380 patients with newly diagnosed MM (NDMM) who underwent 18F-fluorodeoxyglucose (18F-FDG) PET/CT upon diagnosis. The K-adaptive partitioning algorithm was adopted to define subgroups with homogeneous survival. The combined R-ISS with PET/CT classified NDMM patients into four groups: R-ISS/PET stage I (n = 31; R-ISS I with FL ≤ 3), stage II (n = 156; R-ISS I with FL > 3 and R-ISS II with FL ≤ 3), stage III (n = 162; R-ISS II with FL > 3 and R-ISS III with FL ≤ 3), and stage IV (n = 31; R-ISS III with FL > 3). The 2-year overall survival rates for stages I, II, III, and IV were 96.7%, 89.8%, 74.7%, and 50.3%. The 2-year progression-free survival rates were 84.1%, 64.7%, 40.8%, and 17.1%, respectively. The new R-ISS/PET was successfully validated in an external cohort. This new system had a remarkable prognostic power for estimating the survival outcomes of patients with NDMM. This system helps discriminate patients with a good prognosis from those with a poor prognosis more precisely.
format article
author Hee Jeong Cho
Sung-Hoon Jung
Jae-Cheol Jo
Yoo Jin Lee
Sang Eun Yoon
Sung-Soo Park
Do Young Kim
Ho-Jin Shin
Yeung-Chul Mun
Jun Ho Yi
Hyo Jung Kim
Da Jung Kim
Ho Sup Lee
Sung Hwa Bae
Chae Moon Hong
Shin Young Jeong
Jung-Joon Min
Sang Kyun Sohn
Chang-Ki Min
Kihyun Kim
Je-Jung Lee
Joon Ho Moon
The Korean Multiple Myeloma Working Party
author_facet Hee Jeong Cho
Sung-Hoon Jung
Jae-Cheol Jo
Yoo Jin Lee
Sang Eun Yoon
Sung-Soo Park
Do Young Kim
Ho-Jin Shin
Yeung-Chul Mun
Jun Ho Yi
Hyo Jung Kim
Da Jung Kim
Ho Sup Lee
Sung Hwa Bae
Chae Moon Hong
Shin Young Jeong
Jung-Joon Min
Sang Kyun Sohn
Chang-Ki Min
Kihyun Kim
Je-Jung Lee
Joon Ho Moon
The Korean Multiple Myeloma Working Party
author_sort Hee Jeong Cho
title Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
title_short Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
title_full Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
title_fullStr Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
title_full_unstemmed Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
title_sort development of a new risk stratification system for patients with newly diagnosed multiple myeloma using r-iss and 18f-fdg pet/ct
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/0960ae35758a464c82ae284b692a6988
work_keys_str_mv AT heejeongcho developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT sunghoonjung developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT jaecheoljo developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT yoojinlee developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT sangeunyoon developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT sungsoopark developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT doyoungkim developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT hojinshin developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT yeungchulmun developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT junhoyi developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT hyojungkim developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT dajungkim developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT hosuplee developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT sunghwabae developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT chaemoonhong developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT shinyoungjeong developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT jungjoonmin developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT sangkyunsohn developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT changkimin developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT kihyunkim developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT jejunglee developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT joonhomoon developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
AT thekoreanmultiplemyelomaworkingparty developmentofanewriskstratificationsystemforpatientswithnewlydiagnosedmultiplemyelomausingrissand18ffdgpetct
_version_ 1718371879807352832